GenomesDAO GENOME is projected to decline to $0.0001984 by 2027, a -41% move from its current price of $0.0003368. GENOME is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell. Market sentiment sits at 27/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $0.0003245 | $0.0003365 | $0.0003489 | -0.08% |
| Aug 3 | $0.0003194 | $0.0003362 | $0.000354 | -0.16% |
| Aug 4 | $0.0003154 | $0.0003359 | $0.0003578 | -0.24% |
| Aug 5 | $0.0003121 | $0.0003357 | $0.000361 | -0.32% |
| Aug 6 | $0.0003092 | $0.0003354 | $0.0003638 | -0.40% |
| Aug 7 | $0.0003066 | $0.0003351 | $0.0003663 | -0.48% |
| Aug 8 | $0.0003041 | $0.0003349 | $0.0003687 | -0.56% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.0003041 | $0.0003349 | $0.0003687 | -0.56% |
| Week 2 | $0.0002906 | $0.000333 | $0.0003815 | -1.13% |
| Week 3 | $0.0002803 | $0.0003311 | $0.0003911 | -1.68% |
| Week 4 | $0.0002716 | $0.0003292 | $0.0003991 | -2.24% |
| Week 5 | $0.000264 | $0.0003274 | $0.0004059 | -2.79% |
| Week 6 | $0.0002572 | $0.0003255 | $0.000412 | -3.34% |
| Week 7 | $0.0002509 | $0.0003237 | $0.0004175 | -3.89% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
GENOME is the new token from GenomesDAO - Replacing $GENE and $GNOME to create one new super utility token for the Genomes platform.
GENOME sits within the Ethereum Ecosystem, Base Ecosystem, and Decentralized Science (DeSci).
As described, GENOME is positioned as a single, broad utility token for the Genomes platform.
GENOME trades at $0.0003398 and has a market cap of $339.82K. It ranks 3952 by market capitalization.
The near-term outlook reflects a bearish technical backdrop, with RSI and moving averages suggesting limited upside in the immediate horizon. Key levels to watch are support at $0.0003179 and resistance at $0.0004053.
The current price context sits near a shallow trough relative to its all-time high of $0.0586 and above its all-time low of $0.0002974, underscoring tight price action in a low-price tier.
A major floor 9.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.1% away) — a key level to hold.
The nearest ceiling, 14.4% above — a clean break opens room to run.
A major ceiling 36.1% above — clearing it would confirm fresh momentum.
Key GENOME support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GENOME market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.0003607 | Sell | $0.0003562 | Sell |
| MA 10 | $0.000363 | Sell | $0.0003607 | Sell |
| MA 20 | $0.000363 | Sell | $0.0003627 | Sell |
| MA 50 | $0.0003609 | Sell | $0.000369 | Sell |
| MA 100 | $0.0003844 | Sell | $0.0004212 | Sell |
| MA 200 | $0.0005117 | Sell | $0.000755 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.12 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -204.73 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -7.24 | Sell |
| Bollinger %B (20,2) | -0.07 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.02 | Buy |
| Awesome (5,34) | -0.00 | Sell |
| Ultimate (7,14,28) | 35.04 | Neutral |
| Momentum (10) | -0.00 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 0.00 | Sell |
| ADX (14) | 7.14 | Neutral |
| ATR (14) | 0.00 | Info |
The 30-day picture shows a range from $0.000273 to $0.000423, highlighting a tight, low-price band.
RSI14 is 40, indicating room for momentum to shift; the 50-day and 200-day moving levels sit at $0.0003614 and $0.0006065 respectively.
Support sits at $0.0003179 and resistance at $0.0004053, framing a cautious near-term path for GENOME.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.0003106 | $0.0003368 | $0.0003844 | 0% | Neutral | |
| $0.0001534 | $0.0001984 | $0.000274 | -41% | Bearish | |
| $0.0003318 | $0.0004463 | $0.0006467 | +33% | Bullish | |
| $0.0003169 | $0.0004403 | $0.000662 | +31% | Bullish | |
| $0.0001299 | $0.0001858 | $0.0002881 | -45% | Bearish | |
| $0.0002365 | $0.0003474 | $0.0005532 | +3% | Neutral | |
| $0.0003929 | $0.0005918 | $0.0009651 | +76% | Bullish | |
| $0.000217 | $0.0003346 | $0.0005575 | -1% | Neutral | |
| $0.0001474 | $0.0002325 | $0.000395 | -31% | Bearish | |
| $0.000365 | $0.0005882 | $0.001018 | +75% | Bullish | |
| $0.0003037 | $0.000541 | $0.001009 | +61% | Bullish | |
| $0.0005683 | $0.001214 | $0.002522 | +260% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.0003106 | $0.0003368 | $0.0004254 | +0.00% |
| September 2026 | $0.0003068 | $0.0003666 | $0.000453 | +8.85% |
| October 2026 | $0.0002594 | $0.0003128 | $0.000392 | -14.67% |
| November 2026 | $0.0002248 | $0.0002731 | $0.0003461 | -12.70% |
| December 2026 | $0.0002454 | $0.0003003 | $0.0003844 | +9.95% |
Click any year to see its month-by-month GENOME forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, GENOME could reach as high as $0.0003844, with a base case around $0.0003368 and support toward $0.0003106 — roughly 0% from $0.0003368. Price action looks broadly range-bound.
Expect GENOME to range from $0.0001534 to $0.000274 through 2027. The $0.0001984 average target implies a -41% move from current prices. That is -41% versus the projected 2026 average. Expect choppier, lower action through this leg of the cycle.
The GENOME price prediction for 2028 points to an average of $0.0004463 (low $0.0003318, high $0.0006467) — a potential gain of +33% on today's $0.0003368. Momentum favours further upside here.
In 2029, GENOME is projected to trade between $0.0003169 and $0.000662, averaging $0.0004403 — a potential gain of +31% from today's $0.0003368. That is -1% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
GenomesDAO GENOME's 2030 outlook centres on $0.0001858, within a $0.0001299 to $0.0002881 range. That is -58% versus the projected 2029 average. That marks a -45% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2031, GENOME could reach as high as $0.0005532, with a base case around $0.0003474 and support toward $0.0002365 — roughly +3% from $0.0003368. A consolidation phase looks the most probable path here.
Expect GENOME to range from $0.0003929 to $0.0009651 through 2032. The $0.0005918 average target implies a +76% move from current prices. That is up +70% on the projected 2031 average. Momentum favours further upside here.
The GENOME price prediction for 2033 points to an average of $0.0003346 (low $0.000217, high $0.0005575) — a potential decline of -1% on today's $0.0003368. A consolidation phase looks the most probable path here.
In 2034, GENOME is projected to trade between $0.0001474 and $0.000395, averaging $0.0002325 — a potential decline of -31% from today's $0.0003368. That is -31% versus the projected 2033 average. A cyclical pullback looks likely — prices rarely move in a straight line.
GenomesDAO GENOME's 2035 outlook centres on $0.0005882, within a $0.000365 to $0.001018 range. That is up +153% on the projected 2034 average. That marks a +75% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, GENOME could reach as high as $0.001009, with a base case around $0.000541 and support toward $0.0003037 — roughly +61% from $0.0003368. Momentum favours further upside here.
Expect GENOME to range from $0.0005683 to $0.002522 through 2050. The $0.001214 average target implies a +260% move from current prices. That is up +124% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in GENOME today (≈ 2,969,473.809241 GENOME) could be worth
$3,603.75
+$2,603.75 (+260%) by 2050 · US Dollar
Based on the average projected GENOME price of $0 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GENOMEwould be worth at today's price.
$1,000 invested in GENOME on Aug 1, 2025 (≈ 187,177.311182 GENOME) would be worth
$63.03
-$936.97 (-93.7%) today · 0.06× · US Dollar
Based on a GENOME entry price of $0.005343 vs. today's $0.000337.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.000361 | $932.69 | -6.7% |
| 1 month ago | $0.000339 | $993.16 | -0.7% |
| 3 months ago | $0.000499 | $675.18 | -32.5% |
| 6 months ago | $0.000679 | $495.95 | -50.4% |
| 1 year ago | $0.005343 | $63.03 | -93.7% |
| All time (1.2y) ago | $0.006407 | $52.56 | -94.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GENOME forecast.
Our base-case forecast reaches $0.00067 around 2050.
Implied market cap at $0.00067: $670K
The year-by-year forecast shows a mixed path, starting with 2026 where the avg is $0.0003398 and ROI is 0, with sentiment NEUTRAL.
The 2027 forecast enters a bearish phase (avg $0.0001945; ROI -42.8; sentiment BEARISH), followed by a bullish uptick in 2028 (avg $0.0004757; ROI 40; sentiment BULLISH) and 2029 (avg $0.0004265; ROI 25.5; sentiment BULLISH).
In 2030 the outlook turns bearish again (avg $0.000148; ROI -56.5; min $0.0001007; max $0.0002359; sentiment BEARISH), with gradual recovery into 2031 (avg $0.000431; ROI 26.8; sentiment BULLISH) and 2032 (avg $0.0005944; ROI 74.9; sentiment BULLISH).
The forecast also shows a continued cycle of volatility, with 2033 (avg $0.0002482; ROI -27; sentiment BEARISH) and 2034 (avg $0.0002996; ROI -11.8; sentiment NEUTRAL) before a strong upside in 2035 (avg $0.0006525; ROI 92; sentiment BULLISH). The longer horizon includes 2040 (avg $0.0005984; ROI 76.1; sentiment BULLISH) and a notable long-run peak in 2050 (avg $0.001195; ROI 251.8; max $0.002596; sentiment BULLISH; min $0.0005379).
These numbers illustrate a wide range of potential outcomes, with meaningful upside possible by mid-to-late decade and a significant long-horizon rise suggested by 2050. They are estimates, not guarantees, and reflect substantial volatility across the forecast.
Tap a question to reveal the answer.
2030 avg $0.000148; ROI -56.5; sentiment BEARISH. Min $0.0001007; Max $0.0002359.
Forecasts show a mix of gains and declines across years. Notable bullish years include 2028 (avg $0.0004757, ROI 40) and 2050 (avg $0.001195, ROI 251.8); bearish years include 2027 (avg $0.0001945, ROI -42.8) and 2030 (avg $0.000148, ROI -56.5). These are estimates, not guarantees.
The forecast points to a long-horizon target around $0.001, with 2050 avg $0.001195 and max $0.002596; 2040 also shows a path toward higher levels. Min values in the forecast (e.g., 2030 min $0.0001007, 2034 min $0.0001825) illustrate downside risk.
Current price $0.0003398; market cap $339.82K; rank 3952.
RSI14 40; SMA50 $0.0003614; SMA200 $0.0006065. The 30-day range is $0.000273 to $0.000423, with support at $0.0003179 and resistance at $0.0004053; sentiment is BEARISH.
GenomesDAO GENOME Community Discussion
0Share your GenomesDAO GENOME price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.